Free Trial

MetLife (MET) Stock Price, News & Analysis

MetLife logo
$101.79 -0.08 (-0.08%)
As of 11:03 AM Eastern
This is a fair market value price provided by Massive. Learn more.

About MetLife Stock (NYSE:MET)

Advanced

Key Stats

Today's Range
$101.52
▼
$103.46
50-Day Range
$94.24
▼
$103.61
52-Week Range
$67.33
▼
$106.72
Volume
301,427 shs
Average Volume
3.57 million shs
Market Capitalization
$63.97 billion
P/E Ratio
13.28
Dividend Yield
2.33%
Price Target
$107.13
Consensus Rating
Moderate Buy

Company Overview

MetLife, Inc. is a global financial services company best known for providing insurance, employee benefits and retirement-related products. Its offerings include life, dental and disability insurance, annuities, and products and services designed to help individuals and employers plan for financial protection and retirement.

The company serves individuals, businesses and institutions in the United States and international markets, including countries in Latin America, Asia, Europe and the Middle East. Its business includes group benefits for employers as well as insurance and financial products distributed through workplace and individual channels.

MetLife traces its history to 1868, when it was established in New York as a life insurance company. Over time, it expanded beyond its original business to become an international provider of insurance and financial services.

AI Generated. May Contain Errors.

MetLife Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
96th Percentile Overall Score

MET MarketRank™: 
4.806760120525 of 5 stars

MetLife scored higher than 96% of companies evaluated by MarketBeat, and ranked 111th out of 852 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MetLife has received a consensus rating of Moderate Buy. The company's average rating score is 2.93, and is based on no strong buy ratings, 14 buy ratings, 1 hold rating, and no sell ratings.

  • Upside/Downside

    The consensus price target for MetLife is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    MetLife has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about MetLife's stock forecast and price target.
  • Earnings Growth

    Earnings for MetLife are expected to grow by 8.15% in the coming year, from $9.94 to $10.75 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MetLife is 13.28, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.74.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MetLife is 13.28, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 19.67.

  • Price to Earnings Growth Ratio

    MetLife has a PEG Ratio of 0.97. PEG Ratios around 1 indicate that a company is correctly valued.

  • Price to Book Value per Share Ratio

    MetLife has a P/B Ratio of 2.84. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.68% of the float of MetLife has been sold short.
  • Short Interest Ratio / Days to Cover

    MetLife has a short interest ratio ("days to cover") of 3.43, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MetLife has recently decreased by 0.11%, indicating that investor sentiment is improving.
  • Dividend Yield

    MetLife pays a meaningful dividend of 2.30%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    MetLife has been increasing its dividend for 12 years.

  • Dividend Coverage

    The dividend payout ratio of MetLife is 30.90%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, MetLife will have a dividend payout ratio of 22.05% next year. This indicates that MetLife will be able to sustain or increase its dividend.

  • Read more about MetLife's dividend.
  • News Sentiment

    MetLife has a news sentiment score of 0.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Finance companies.
  • News Coverage This Week

    MarketBeat has tracked 28 news articles for MetLife this week, compared to 9 articles on an average week.
  • Search Interest

    9 people have searched for MET on MarketBeat in the last 30 days. This is an increase of 29% compared to the previous 30 days.
  • MarketBeat Follows

    18 people have added MetLife to their MarketBeat watchlist in the last 30 days. This is an increase of 350% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, MetLife insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $19,299,152.00 in company stock.

  • Percentage Held by Insiders

    0.40% of the stock of MetLife is held by insiders.

  • Percentage Held by Institutions

    94.99% of the stock of MetLife is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about MetLife's insider trading history.
Receive MET Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MetLife and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MET Stock News Headlines

MetLife (NYSE:MET) Stock: Insider Michel Khalaf Sells 187,425 Shares
MetLife (NYSE:MET) Given New $117.00 Price Target at Mizuho
The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel
MetLife (NYSE:MET) Stock Price Target Raised at Wells Fargo & Company
MetLife (MET) Agrees To Divest MetLife UK Limited
MetLife (NYSE:MET) Stock Gets Price Target Boost from Piper Sandler
MetLife Amends Credit Agreement for Up to $4 Billion
See More Headlines

MET Stock Analysis - Frequently Asked Questions

MetLife's stock was trading at $78.98 at the beginning of 2026. Since then, MET shares have increased by 29.0% and is now trading at $101.8730.

MetLife, Inc. (NYSE:MET) issued its quarterly earnings data on Wednesday, November, 4th. The financial services provider reported $2.78 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.77 by $0.01. The business's revenue for the quarter was up 18.2% compared to the same quarter last year.
Read the conference call transcript
.

MetLife's Board of Directors approved a stock buyback plan on Wednesday, August 5th 2026, which allows the company to repurchase $3 billion in outstanding shares, according to EventVestor. This means that the company could repurchase up to 4.9% of its stock through open market purchases. Stock repurchase plans are often an indication that the company's leadership believes its shares are undervalued.

MetLife subsidiaries include these companies: Versant Health, Willing, Logan Circle Partners, American Life Insurance Company, Safeguard Health Enterprises, Grand Bank N.A., General American Life Insurance Company, and more.

MetLife's top institutional investors include State Street Corp (3.99%), Pzena Investment Management LLC (1.64%), Bessemer Group Inc. (0.30%) and Russell Investments Group Ltd. (0.27%). Insiders that own company stock include Michel Khalaf, Ramy Tadros and Bill Pappas.
View institutional ownership trends
.

Shares of MET stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MetLife investors own include AT&T (T), Verizon Communications (VZ), Pfizer (PFE), ExxonMobil (XOM), Bank of America (BAC), GE Aerospace (GE) and Johnson & Johnson (JNJ).

Company Calendar

Record date for 9/8 Dividend
8/04/2026
Ex-Dividend for 9/8 Dividend
8/04/2026
Dividend Payable
9/08/2026
Record date for 12/8 Dividend
11/03/2026
Ex-Dividend for 12/8 Dividend
11/03/2026
Last Earnings
11/04/2026
Today
11/13/2026
J.P. Morgan European Financials Conference
11/19/2026
Dividend Payable
12/08/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Finance
Industry
Insurance
Sub-Industry
Life & Health Insurance
Current Symbol
NYSE:MET
CIK
1099219
Employees
46,000
Year Founded
1868

Price Target and Rating

High Price Target
$117.00
Low Price Target
$80.00
Potential Upside/Downside
+5.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.93
Research Coverage
15 Analysts

Profitability

EPS (Trailing Twelve Months)
$7.67
Trailing P/E Ratio
13.34
Forward P/E Ratio
9.49
P/E Growth
0.97
Net Income
$3.38 billion
Net Margins
6.21%
Pretax Margin
8.07%
Return on Equity
25.71%
Return on Assets
0.92%

Debt

Debt-to-Equity Ratio
0.65
Current Ratio
0.21
Quick Ratio
0.20

Sales & Book Value

Annual Sales
$77.08 billion
Price / Sales
0.83
Cash Flow
$7.68 per share
Price / Cash Flow
13.29
Book Value
$35.83 per share
Price / Book
2.85

Miscellaneous

Outstanding Shares
628,440,000
Free Float
625,928,000
Market Cap
$64.11 billion
Optionable
Optionable
Beta
0.79

Social Links

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (NYSE:MET) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners